Third Party Risk Assessment Tailored to You

What the new BIS 50% Rule Means for Third-Party Screening & Ownership Due Diligence

On September 29, 2025, the Bureau of Industry and Security of the US Department of Commerce (“BIS”) issued a new interim final rule [...]

The Importance of TPRM in Facilitating Ethical Transactions with HCPs

In the Life Sciences industry, maintaining ethical and transparent relationships with healthcare professionals (HCPs) is fundamental to trust, patient safety, and business integrity. [...]

Agility, Innovation & Strong (Ethical) Foundations

Earlier this month, Ethixbase360 was delighted to sponsor the third annual Risk & Compliance Pharma & Life Sciences Conference, held in London. [...]

The Business Value of Tcertification

Virna Di Palma, Head of Global Content & Brand at Ethixbase360, highlights how Tcertification creates measurable business value.

Why Supply Chain Risk Management Matters

Peter Nestor, Global Head of Human Rights at Novartis, explains why managing supply chain risks is now central to business resilience.

CSDDD in Transition – Has the EU Omnibus Package Gone Too Far? What’s Next for Companies and Human Rights Compliance

As debate continues over the EU Omnibus Proposal—unlikely to be finalized before 2026—many companies are questioning whether the package has […]